Literature DB >> 4610076

Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens.

C W Pierce, J A Kapp, S M Solliday, M E Dorf, B Benacerraf.   

Abstract

The effects of alloantisera against leukocyte alloantigens on plaque-forming cell (PFC) responses to sheep erythrocytes and the terpolymer of L-glutamic acid(60)-L-alanine(30)-L-tyrosine(10) (GAT) by mouse spleen cells in vitro have been investigated. Polyspecific antibodies against both H-2 and non-H-2 alloantigens on responding spleen cells suppressed both IgM and IgG PFC responses; antisera against alloantigens coded for by the K and I regions, but not the D region, of the H-2 complex also effectively suppressed PFC responses. The suppression was not due to cytotoxicity to the spleen cells or anti-immunoglobulin activity in the sera and was directly related to the amount of antiserum added to the cultures. The suppression was specific for spleen cells against which the alloantiserum was directed. The alloantisera suppressed responses most effectively when present during the first 24 h of incubation, and although not rendering lymphoid cells incapable of developing PFC responses after removal of noncell-bound antibody, did act by interfering with successful initiation of the PFC response. The alloantisera suppressed both IgM and IgG PFC responses when directed against alloantigens only on macrophages, but selectively suppressed IgG responses when directed against alloantigens only on lymphoid cells. The alloantisera did not interfere with the ability of macrophages to bind GAT or to support the viability of the lymphoid cells, but did interfere with the ability of macrophage-associated antigen to effectively stimulate antibody responses by the lymphoid cells. Possible mechanisms for the effects of alloantisera on macrophages and the selective suppression of IgG responses when the antisera are directed against alloantigens on lymphoid cells are discussed with reference to our current understanding of genetic restrictions governing cell interactions in the development of antibody responses in mice.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4610076      PMCID: PMC2139626          DOI: 10.1084/jem.140.4.921

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

Review 1.  Cell-cell interactions in antibody production.

Authors:  H N Claman; D E Mosier
Journal:  Prog Allergy       Date:  1972

2.  Cell interactions in antibody formation in vitro. I. Role of the third cell in the in vitro response of spleen cells to erythrocyte antigens.

Authors:  H Cosenza; L D Leserman
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

3.  Biologically active water-insoluble protein polymers. I. Their use for isolation of antigens and antibodies.

Authors:  S Avrameas; T Ternynck
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

Review 4.  Biochemical and biological characteristics of lymphocyte surface immunoglobulin.

Authors:  J J Marchalonis; R E Cone
Journal:  Transplant Rev       Date:  1973

Review 5.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

6.  Immune responses in vitro. IV. Suppression of primary M, G, and A plaque-forming cell responses in mouse spleen cell cultures by class-specific antibody to mouse immunoglobulins.

Authors:  C W Pierce; S M Solliday; R Asofsky
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

7.  H-2 dependence of co-operation between T and B cells in vivo.

Authors:  B Kindred; D C Shreffler
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

8.  Histocompatibility-linked immune response gene function in guinea pigs. Specific inhibition of antigen-induced lymphocyte proliferation by alloantisera.

Authors:  E M Shevach; W E Paul; I Green
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

9.  Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes.

Authors:  D H Katz; E R Unanue
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

10.  Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.

Authors:  C W Pierce; B M Johnson; H E Gershon; R Asofsky
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more
  7 in total

1.  Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p23, 30 antigen.

Authors:  S M Friedman; J M Breard; R E Humphreys; J L Strominger; S F Schlossman; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

2.  Physiological regulation of antigen binding to T cells: role of a soluble macrophage factor and of interferon.

Authors:  P Lonai; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Genetic control of immune responses in vitro. VI. Experimental conditions for the development of helper T-cell activity specific for the terpolymer L-glutamic aicd60-L-alanine30-L-tyrosine10 (GAT) in nonresponder mice.

Authors:  J A Kapp; C W Pierce; B Benacerraf
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

4.  Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.

Authors:  M Pierres; R N Germain; M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

5.  Regulation by the H-2 gene complex of macrophage-lymphoid cell interactions in secondary antibody responses in vitro.

Authors:  C W Pierce; J A Kapp; B Benacerraf
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

6.  Major histocompatibility complex-restricted self recognition. A monoclonal anti-I-Ak reagent blocks helper T cell recognition of self major histocompatibility complex determinants.

Authors:  R J Hodes; K S Hathcock; A Singer
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

7.  In vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants.

Authors:  M Pierres; R N Germain; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.